USP18 and breast cancer: The above findings, together with the fact that USP18 deficiency creates antitumor activity in mammary cells [98], suggest that miR193a-3p may prevent MCF-7 and LEC cross-talk and abrogate IFN-driven angiogenic processes in BC, inhibiting growth.